Serum Albumin Levels Strongly Predict Survival Outcome of Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab-Combined Chemotherapy

Background: In the current Japanese aging society, a high number of very elderly patients (age ranged from 80 to 93) with diffuse large B-cell lymphoma (DLBCL, most frequent hematological malignancy), who require chemotherapy are encountered. However, standard chemotherapy can result in severe adver...

Полное описание

Библиографические подробности

Главные авторы:	Hiroto Kaneko, Kazuho Shimura, Mihoko Yoshida, Yosuke Matsumoto, Tsutomu Kobayashi, Hitoji Uchiyama, Junya Kuroda, Masafumi Taniwaki
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Tehran University of Medical Sciences 2022-01-01
Серии:	International Journal of Hematology-Oncology and Stem Cell Research
Предметы:	Diffuse large B-cell lymphoma; Elderly; Rituximab combined cyclophosphamide; Doxorubicin; Vincristine and prednisolone (R-CHOP); Albumin
Online-ссылка:	https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/1316
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!